Covid-19 vaccine for 5 to 11-year-olds is safe and shows 'robust' antibody response, Pfizer says
By Mikeandeleven in News
Updated 3 years ago
A Phase 2/3 trial of Pfizer/BioNTech's two-dose Covid-19 vaccine for children ages 5 to 11 showed it is safe and generated a "robust" antibody response.
